Twist Bioscience (TWST) Market Cap

Price: $40.36
Market Cap: $2.41B
Avg Volume: 954.19K
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Beta: 2.146
52W Range: $27.41-60.9
Website: Twist Bioscience

Market Cap Overview

Market Cap

$2.41B

Share Price

$40.36

Shares Outstanding

59.65M


What is Twist Bioscience's Market Cap?

Twist Bioscience's current Market Cap as of today is $2.41B.

Understanding Market Capitalization

Market Capitalization (Market Cap) is the total value of a company's outstanding shares of stock. It is calculated by multiplying the current market price of one share by the total number of outstanding shares.

  • It provides a straightforward method of gauging a company's size.
  • Market Cap can be used to compare companies within the same industry.

How is Market Cap calculated?

Market Cap is calculated by multiplying the current share price by the total number of outstanding shares:

Market Cap = Current Share Price × Total Shares Outstanding

In the case of Twist Bioscience, the market cap is calculated as $40.36 x 59.65M shares = $2.41B.

As a Mid Cap company, Twist Bioscience is a medium-sized company with significant growth potential.

Twist Bioscience Historical Market Cap

$12.00B$12.00B$9.00B$9.00B$6.00B$6.00B$3.00B$3.00B$0.00$0.00Market CapJul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV

Twist Bioscience Market Cap vs Enterprise Value

Understanding Market Cap vs. Enterprise Value

While market cap represents the equity value of Twist Bioscience, enterprise value provides a more complete picture of the company's total value by including debt and cash:

Market Cap
Enterprise Value
$8.00B$8.00B$6.00B$6.00B$4.00B$4.00B$2.00B$2.00B$0.00$0.00ValueJul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV

Enterprise Value = Market Cap + Total Debt - Cash and Equivalents

Twist Bioscience's enterprise value as of December 31, 2024 (Q1 2025) is calculated as:

  • Market Cap: $2.41B
  • Total Debt: $82.62M
  • Cash and Equivalents: $221.40M
  • Enterprise Value: $2.61B

The difference between market cap and enterprise value can indicate the company's financial leverage and cash position. A higher enterprise value suggests significant debt levels.

Twist Bioscience Annual Market Cap History

Year Market Cap Change
2025 $2.41B -8.15%
2024 $2.62B 127.43%
2023 $1.15B -39.31%
2022 $1.90B -63.21%
2021 $5.16B 73.36%
2020 $2.98B 354.00%
2019 $655.79M 76.03%
2018 $372.54M 41.69%
2017 $262.93M 0.00%
2016 $262.93M N/A

Frequently Asked Questions

Twist Bioscience's current market capitalization is $2.41B. This makes it a Mid Cap company, calculated by multiplying its current stock price of $40.36 by 59.65M outstanding shares.

Twist Bioscience's enterprise value is $2.61B. This is calculated by adding total debt ($82.62M) to market cap and subtracting cash and equivalents ($221.40M). Enterprise value provides a more complete picture of the company's total value by considering both its debt and cash positions.

Twist Bioscience has 59.65M shares outstanding. This number represents the total number of shares currently held by all shareholders, including company insiders, institutional investors, and the public.

Twist Bioscience is classified as a Mid Cap company. Mid-cap companies are established companies with market caps between $2 billion and $10 billion.

Twist Bioscience's market cap is calculated by multiplying its current stock price ($40.36) by its total number of outstanding shares (59.65M). This calculation represents the total market value of all the company's outstanding shares at the current market price.

Related Metrics

Explore detailed financial metrics and analysis for TWST.